While announcing OHSU’s involvement in an international clinical trial assessing monoclonal antibodies for COVID therapy, Akram Khan, M.D., notes antibodies can decrease viral replication, “allowing the body to repair and heal itself.”

In a story about Oregon wanting to review COVID vaccine clinical trial data before allowing federally approved vaccines to be administered in the state, Mark Slifka, Ph.D., notes the COVID-19 vaccine development process has been accelerated, but vaccine trials still needs to involve thousands of people to ensure experimental vaccines are safe.

In a story about national primate research centers seeking support to compare potential COVID vaccines and treatments in nonhuman primates, Nancy Haigwood, Ph.D., says “This is not a competition with Warp Speed. The goal here is to have data that are additive.”

A Ubiquitome press release includes comment from Steven Kazmierczak, Ph.D., who led clinical studies for Liberty16 mobile PCR technology. He says: “The Liberty16 came through as fast, accurate and competitive for the cost of testing and the device itself.”

Richard Mick Scanlan, M.D., is quoted about the dangers of an over-reliance on testing to prevent the type of workplace outbreak that occurred at the White House. He says: “[It’s] what we call a window period: that’s the period after you get infected and before you test positive.”

Gopal Allada, M.D., discussing President Trump's COVID-19 diagnosis, says: “In the immediate term, the biggest risks are to those around him, if they’re not socially distancing and mask-protected.”

Magazine features new building nearly finished in downtown Portland as a collaboration between OHSU, Portland Community College, the city of Portland and Portland State University.

Donna Hansel, M.D., Ph.D., says this of Oregon’s new rapid COVID tests: “It really expands capacity to bring testing to areas that don’t have a large hospital presence. It also allows for people who are symptomatic to get a really quick test and get those results back so they can isolate. It will also just allow us to test 60 to 80 thousand more people a week."

OHSU visiting researcher Damien Fair, P.A.-C., Ph.D., is named as a 2020 MacArthur Fellow. He says of the recognition: “I work with some of the most brilliant minds on the planet, many of who are deserving of such an award. So, it is very humbling, to be honest."

A Smile for Kids press release announces work with OHSU to evaluate the organizations impact Oregon youth.